Topics and Expertise: health economics

Associate Professor

I am a member of the Center for Translational and Policy Research on Precision Medicine (TRANSPERS). I work on applied and methods research to understand the clinical and economic value of drugs and other health technologies.

The patient perspective on prosthetic limbs currently doesn’t factor into the FDA approval process. Leslie Wilson and Matthew Garibaldi are surveying patient preferences to speed access to the next generation of prosthetics.

Every day, on average, ten new genetic tests become commercially available to help doctors and patients make more informed decisions about health care.

A new study lead-authored by UCSF School of Pharmacy faculty member James Lightwood, PhD, has found that reducing smoking cuts health care spending, not just in the long- or immediate-term, but the very next year.

Professor

My work focuses on the translation of new technologies into improved patient outcomes, particularly the translation of personalized/precision medicine—targeting health care interventions to patients based on their genetics—into clinical care and health policy.

California tobacco control efforts that cost $2.4 billion over nearly two decades reduced health care costs during that same period by $134 billion, according to a new study co-authored by UCSF School of Pharmacy faculty member James Lightwood, PhD.

Health economist Leslie Wilson, PhD, faculty member in the UCSF School of Pharmacy, studies the ratio of cost to benefit, the benefit alone, or the cost alone of health treatments, educational interventions, and other activities that can ultimately impact a patient's health.